<DOC>
	<DOCNO>NCT02575690</DOCNO>
	<brief_summary>Potential protective cardiovascular effect Spirulina maximum supplementation study double-blind placebo-controlled trial obese subject treat hypertension , randomize receive spirulina placebo .</brief_summary>
	<brief_title>Spirulina Supplementation Cardiovascular Risk Obese Caucasians With Treated Hypertension</brief_title>
	<detailed_description>Numerous publication provide evidence effect natural substances-supplements improve endothelial function , thus reduce risk cardiovascular disease . Spirulina maximum ( Arthrospira maximum ) species cyanobacterium , use food additive high level protein essential nutrient , carotenoid , vitamin , mineral . Various study point possible beneficial effect spirulina concentration blood serum lipid fast glucose , body weight blood pressure , however , result study pertain effect spirulina individual , time trial , take medication . The aim study estimate effect Spirulina maximum supplementation cardiovascular risk obese Caucasians treat hypertension . The anthropometric parameter , blood pressure , insulin sensitivity , plasma lipid level , stress oxidative biomarkers measure baseline 3 month supplementation spirulina placebo group obese , hypertensive patient receive standard antihypertensive treatment .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<criteria>body mass index ( BMI ) equal great 30 kg/m2 age 25 60 year stable body weight ( &lt; 3 kg selfreported change previous three month ) wellcontrolled hypertension ( mean systolic blood pressure ( SBP ) less 160 mmHg and/or diastolic blood pressure ( DBP ) less 100 mmHg ) stable treatment least 6 month ( patient receive one drug ) secondary obesity secondary hypertension diabetes history coronary artery disease stroke congestive heart failure malignancy history use dietary supplement within three month prior study current need modification antihypertensive therapy abnormal liver kidney function clinically significant process history infection month prior study nicotine alcohol abuse condition , opinion investigator , would make participation best interest patient could prevent , limit , confound protocolspecified efficacy assessment</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>spirulina , placebo , obesity , antihypertensive treatment</keyword>
</DOC>